MEDS DataMeds AI, Inc. stock chart & analysis
Conviction 36HealthcareScan · Wed, Nov 4, 2026DataMeds AI, Inc. (MEDS) closed at $1.51 (-16.11%) on Nov 4, 2026. Price is below its 50-day. RSI(14) 34, -87.7% from its 52-week high, -80.1% year to date. Sector: Healthcare.
Why MEDS moved
From the StockSetups movers recaps that covered MEDS, newest first. A recap states what was known that day.
- Premarket+25.7%
Yahoo Finance is reporting this morning that DataMeds AI and Tollo Health announced the launch of the "Health Lives Here" mobile application — a consumer-facing health platform. This is a concrete product launch catalyst.
Premarket Movers Sept 28, 2026: KOD, GYGY, CLRO → - Premarket+321.0%
According to Advfn, Quiver Quantitative, and StocksToTrade (all dated September 16), DataMeds AI has completed a $1.5 million acquisition of Helomics, an oncology laboratory, expanding the company's push into cancer diagnostics.
Premarket Stock Movers — September 17, 2026: Why AEMD, MEDS, DAIC, TURB & KXIN Are Surging → - Premarket+384.2%
According to Yahoo Finance and headlines from September 15, DataMeds AI has acquired the Helomics AI Cancer Diagnostics Lab and Precision Oncology CRO businesses from Axe Compute.
Premarket Stock Movers — September 16, 2026: Why MEDS, ZTG, DLXY, TPST & BENF Are Surging →
Financials as of Tue, Jun 30, 2026 · quarterly.
MEDS technical analysis
Trend
It closed 39.3% below the 50-day ($2.49). ADX(14) at 38 points to a strong, established trend.
Momentum
RSI(14) is 34, in the bearish half of its range. The MACD histogram is negative.
Volume and volatility
Volume on the latest session ran 0.0× its 20-day average. It trades about $7.1M a day on average. ATR(14) is $0.4324, 28.6% of price — its typical daily range. On-balance volume is trending up. Chaikin Money Flow (-0.38) shows distribution.
Key levels
The chart pattern's support is $2.27 and its resistance $8.48. The 52-week range is $0.8225 to $12.31; price is 87.7% below the high and 83.6% above the low. The VWAP anchored at the 52-week high is $5.86, above price.
Performance
MEDS returned -31.4% (1 week), -50.8% (1 month), -42.8% (3 months), -80.1% (year to date).
Recent news
- DataMEDS AI Secures Supply Agreement for Six Compounded Peptides Following FDA Advisory Committee RecommendationsAdvfn · Mon, Nov 2, 2026
- DataMeds subsidiary secures peptide supply agreement By Investing.comInvesting.com UK · Mon, Nov 2, 2026
SEC filings
EDGAR filings in MEDS · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.
Start free — 7-day trial, no card →Free daily signals by email. Top 3 setups per lane after every close. No account needed.
Unsubscribe anytime · Privacy
Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.